Anticonvulsant drugs in cocaine dependence: A systematic review and meta-analysis

Journal of Substance Abuse Treatment

Volumn 38, Issue 1, 2010, Pages 66-73

  Alvarez, Yolanda ^a,b   Farré, Magí ^a,b   Fonseca, Francina ^a   Torrens, Marta ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Anticonvulsant; Cocaine dependence, Retention; Meta analysis; Systematic review

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMATIC REVIEW; URINALYSIS;

ANTICONVULSANTS; CHI-SQUARE DISTRIBUTION; COCAINE-RELATED DISORDERS; CONFIDENCE INTERVALS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 70849112361     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2009.07.001     Document Type: Article

References (32)

1. Aharonovich E., Garawi F., Bisaga A., Brooks D., Raby W.N., Rubin E., et al. Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: Effects on outcome. American Journal of Drug and Alcohol Abuse 32 (2006) 629-635
2. Ahmadi J., Kampman K.M., Oslin D.M., Pettinati H.M., Dackis C., and Sparkman T. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions 18 (2009) 81-86
3. Amato L., Minozzi S., Pani P.P., and Davoli M. Antipsychotic medications for cocaine dependence. Cochrane Database of Systematic Reviews (Online) 3 (2007) CD006306
4. Berger S.P., Winhusen T.M., Somoza E.C., Harrer J.M., Mezinskis J.P., Leiderman D.B., et al. A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction (Abingdon, England) 100 Suppl 1 (2005) 58-67
5. Brady K.T., Sonne S.C., Malcolm R.J., Randall C.L., Dansky B.S., Simpson K., et al. Carbamazepine in the treatment of cocaine dependence: Subtyping by affective disorder. Experimental and Clinical Psychopharmacology 10 (2002) 276-285
6. Campbell J., Nickel E.J., Penick E.C., Wallace D., Gabrielli W.F., Rowe C., et al. Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients. American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions 12 (2003) 122-136
7. Campbell J.L., Thomas H.M., Gabrielli W., Liskow B.I., and Powell B.J. Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: Preliminary findings. Journal of Addictive Diseases 13 (1994) 191-199
8. Castells X., Casas M., Vidal X., Bosch R., Roncero C., Ramos-Quiroga J.A., et al. Efficacy of central nervous system stimulant treatment for cocaine dependence: A systematic review and meta-analysis of randomized controlled clinical trials. Addiction (Abingdon, England) 102 (2007) 1871-1887
9. Cornish J.W., Maany I., Fudala P.J., Neal S., Poole S.A., Volpicelli P., et al. Carbamazepine treatment for cocaine dependence. Drug and Alcohol Dependence 38 (1995) 221-227
10. Crosby R.D., Pearson V.L., Eller C., Winegarden T., and Graves N.L. Phenytoin in the treatment of cocaine abuse: A double-blind study. Clinical Pharmacology and Therapeutics 59 (1996) 458-468
11. Ford J.D., Gelernter J., DeVoe J.S., Zhang W., Weiss R.D., Brady K., et al. Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. Drug and Alcohol Dependence 99 (2009) 193-203
12. Gonzalez G., Desai R., Sofuoglu M., Poling J., Oliveto A., Gonsai K., et al. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug and Alcohol Dependence 87 (2007) 1-9
13. Gonzalez G., Sevarino K., Sofuoglu M., Poling J., Oliveto A., Gonsai K., et al. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: Results of a randomized pilot study. Addiction (Abingdon, England) 98 (2003) 1625-1632
14. Halikas J.A., Crosby R.D., Pearson V.L., and Graves N.M. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. Clinical Pharmacology and Therapeutics 62 (1997) 89-105
15. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 17 (1996) 1-12
16. Kampman K.M., Pettinati H., Lynch K.G., Dackis C., Sparkman T., Weigley C., et al. A pilot trial of topiramate for the treatment of cocaine dependence. Drug and Alcohol Dependence 75 (2004) 233-240
17. Kampman K.M., Volpicelli J.R., Mulvaney F., Rukstalis M., Alterman A.I., Pettinati H., et al. Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors 27 (2002) 251-260
18. Kollins S.H. ADHD, substance use disorders, and psychostimulant treatment: Current literature and treatment guidelines. Journal of Attention Disorders 12 (2008) 115-125
19. Kranzler H.R., Bauer L.O., Hersh D., and Klinghoffer V. Carbamazepine treatment of cocaine dependence: A placebo-controlled trial. Drug and Alcohol Dependence 38 (1995) 203-211
20. Levin F.R., Bisaga A., Raby W., Aharonovich E., Rubin E., Mariani J., et al. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. Journal of Substance Abuse Treatment 34 (2008) 80-89
21. Lima M.S., Reisser A.A., Soares B.G., and Farrell M. Antidepressants for cocaine dependence. Cochrane Database of Systematic Reviews (Online) 2 (2003) CD002950
22. Minozzi S., Amato L., Davoli M., Farrell M., Lima Reisser A.A., Pani P.P., et al. Anticonvulsants for cocaine dependence. Cochrane Database of Systematic Reviews (Online) 2 (2008) CD006754
23. Montoya I.D., Levin F.R., Fudala P.J., and Gorelick D.A. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug and Alcohol Dependence 38 (1995) 213-219
24. Reid M.S., Casadonte P., Baker S., Sanfilipo M., Braunstein D., Hitzemann R., et al. A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/l-carnitine for the treatment of cocaine dependence. Addiction (Abingdon, England) 100 Suppl 1 (2005) 43-57
25. Review Manager (Rev Man). United Kingdom: Retrieved from (2003). http://www.cc-ims.net/RevMan
26. Soares B.G., Lima M.S., Reisser A.A., and Farrell M. Dopamine agonists for cocaine dependence. Cochrane Database of Systematic Reviews (Online) 2 (2003) CD003352
27. Sofuoglu M., and Kosten T.R. Novel approaches to the treatment of cocaine addiction. CNS Drugs 19 (2005) 13-25
28. Torrens M., Fonseca F., Mateu G., and Farre M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug and Alcohol Dependence 78 (2005) 1-22
29. United Nations Office on Drugs and Crime. (2008). World drug report 2008.
30. Volkow N.D., Fowler J.S., and Wang G.J. The addicted human brain: Insights from imaging studies. Journal of Clinical Investigation 111 (2003) 1444-1451
31. Winhusen T., Somoza E., Ciraulo D.A., Harrer J.M., Goldsmith R.J., Grabowski J., et al. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Drug and Alcohol Dependence 91 (2007) 141-148
32. Winhusen T.M., Somoza E.C., Harrer J.M., Mezinskis J.P., Montgomery M.A., Goldsmith R.J., et al. A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction (Abingdon, England) 100 Suppl 1 (2005) 68-77